Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
-3.26%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$43.7B
AUM Growth
-$654M
(-1.5%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
18.76%
Holding
3,868
New
224
Increased
1,970
Reduced
1,386
Closed
163
Top Buys
Top Sells
| 1 |
Vanguard Total International Bond ETF
BNDX
|
$50.6M |
| 2 |
Organon & Co
OGN
|
$31.8M |
| 3 |
DWEQ
AdvisorShares Dorsey Wright Alpha Equal Weight ETF
DWEQ
|
$22.3M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$22.3M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
$21.9M |
Sector Composition
| 1 | Technology | 11.86% |
| 2 | Financials | 5.98% |
| 3 | Healthcare | 4.98% |
| 4 | Consumer Discretionary | 4.84% |
| 5 | Industrials | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Kartoon Studios
TOON
$38.5M
| $40K | ﹤0.01% |
4,014
-5,395
| -57% | -$53.8K |
|
3602
Q32 Bio
QTTB
$20.4M
| $40K | ﹤0.01% |
739
+28
| +4% | +$1.52K |
|
|
VIEW
3603
DELISTED
View, Inc. Class A Common Stock
VIEW
| $40K | ﹤0.01% |
363
+148
| +69% | +$16.3K |
|
|
RGLS
3604
DELISTED
Regulus Therapeutics
RGLS
| $39K | ﹤0.01% |
13,100
+1,200
| +10% | +$3.57K |
|
|
LHDX
3605
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $39K | ﹤0.01% |
+11,000
| New | +$39K |
|
3606
AquaBounty Technologies
AQB
$4.54M
| $38K | ﹤0.01% |
1,030
-866
| -46% | -$32K |
|
3607
Cognition Therapeutics
CGTX
$230M
| $38K | ﹤0.01% |
+13,890
| New | +$38K |
|
|
DPRO
3608
Draganfly
DPRO
$81.5M
| $38K | ﹤0.01% |
+647
| New | +$38K |
|
3609
Atossa Therapeutics
ATOS
$102M
| $37K | ﹤0.01% |
30,283
-159
| -0.5% | -$194 |
|
3610
Momentus
MNTS
$14M
| $37K | ﹤0.01% |
+17
| New | +$37K |
|
3611
Team
TISI
$86.4M
| $36K | ﹤0.01% |
+1,636
| New | +$36K |
|
|
BIOL
3612
DELISTED
Biolase, Inc.
BIOL
| $35K | ﹤0.01% |
40
+21
| +111% | +$18.4K |
|
3613
Cytosorbents Corp
CTSO
$60.6M
| $34K | ﹤0.01% |
10,969
-1,054
| -9% | -$3.27K |
|
|
EMX
3614
EMX Royalty
EMX
$444M
| $34K | ﹤0.01% |
16,019
| – | – |
|
|
ATHX
3615
DELISTED
Athersys, Inc. Common Stock
ATHX
| $34K | ﹤0.01% |
2,271
-80
| -3% | -$1.2K |
|
|
NEWP
3616
New Pacific Metals
NEWP
$352M
| $33K | ﹤0.01% |
10,621
-1,639
| -13% | -$5.09K |
|
3617
Trevi Therapeutics
TRVI
$854M
| $33K | ﹤0.01% |
+15,000
| New | +$33K |
|
3618
XWELL
XWEL
$6.27M
| $33K | ﹤0.01% |
1,460
+753
| +107% | +$17K |
|
3619
GT Biopharma
GTBP
$3.36M
| $32K | ﹤0.01% |
372
+4
| +1% | +$344 |
|
3620
NN Inc
NNBR
$125M
| $32K | ﹤0.01% |
11,265
| – | – |
|
3621
Phunware
PHUN
$50.3M
| $32K | ﹤0.01% |
+235
| New | +$32K |
|
3622
CuriosityStream
CURI
$265M
| $31K | ﹤0.01% |
+10,796
| New | +$31K |
|
3623
Precision BioSciences
DTIL
$59.8M
| $31K | ﹤0.01% |
+342
| New | +$31K |
|
|
RDHL
3624
Redhill Biopharma
RDHL
$3.28M
| $30K | ﹤0.01% |
12
+1
| +9% | +$2.5K |
|
3625
Avalo Therapeutics
AVTX
$153M
| $29K | ﹤0.01% |
14
-4
| -22% | -$8.29K |
|